Secondary hyperaldosteronism and liver fibrosis in patients with compensated chronic liver disease or portal hypertension

Eur J Intern Med. 2022 May:99:118-120. doi: 10.1016/j.ejim.2022.01.020. Epub 2022 Jan 15.

¹ Internal Medicine Unit for the Treatment of Severe Organ Failure, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola, Bologna, Italy. Electronic address: giovanni.vitale@aosp.bo.it.
² Unit of Endocrinology and Prevention and Care of Diabetes, Department of Medical and Surgical Sciences (DIMEC), IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola, Bologna, Italy. Electronic address: kimberly.coscia@studio.unibo.it.
³ Unit of Endocrinology and Prevention and Care of Diabetes, Department of Medical and Surgical Sciences (DIMEC), IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola, Bologna, Italy. Electronic address: guido.zavatta2@unibo.it.
⁴ Internal Medicine Unit for the Treatment of Severe Organ Failure, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola, Bologna, Italy. Electronic address: mariacristina.morelli@aosp.bo.it.
⁵ Unit of Endocrinology and Prevention and Care of Diabetes, Department of Medical and Surgical Sciences (DIMEC), IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola, Bologna, Italy. Electronic address: valentina.vicennati@aosp.bo.it.

No abstract available

Keywords: AST to platelet ratio index; Aldosterone x Renin product; Liver cancer; Renin-angiotensin-aldosterone system.

Publication types